Elina L.
- Country
- Estonia
- Department
- Oncology Clinic
Research Overview
Data & Insights
Has run more than one trial at 0 of 19 partner sites.
Specializations
Oncology – Solid Tumors
Dr. Lehtmaa’s work emphasizes therapeutic strategies for solid malignancies across multiple organ systems.
- Lung cancer – non‑small cell
- Breast cancer – ER+/HER2‑
- Prostate cancer – castration‑resistant
- Melanoma – adjuvant treatment
- Esophageal carcinoma
Her investigations aim to improve survival outcomes in patients with advanced cancer.
Hematologic Malignancies
She focuses on innovative therapies for blood‑derived cancers, particularly leukemia and lymphoma.
- Acute lymphoblastic leukemia
- Acute myeloid leukemia (AML)
- Chronic lymphocytic leukemia (CLL)
- Diffuse large B‑cell lymphoma
- Myelodysplastic syndrome
Her contributions target disease‑specific molecular pathways to achieve durable remission in hematologic disease.
Autoimmune and Inflammatory Disorders
Dr. Lehtmaa is actively engaged in trials addressing chronic immune‑mediated conditions, with a focus on immune modulation.
- Moderate to severe Crohn’s disease
- Ulcerative colitis
- Atopic dermatitis
- Multiple sclerosis – relapsing‑remitting
- Psoriasis – plaque
Her research seeks to reduce disease activity and improve quality of life for patients with autoimmune disease.
Renal and Cardiovascular Medicine
She contributes to studies targeting kidney and heart health, especially conditions linked to vascular risk.
- Immunoglobulin A nephropathy (IgAN)
- Chronic kidney disease – FSGS
- Atherosclerotic cardiovascular disease (ASCVD)
- Hypercholesterolemia
- Heart failure with preserved ejection fraction (HFpEF)
Her efforts aim to mitigate organ damage and prevent major cardiovascular events in at‑risk populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.